E-Book, Englisch, 427 Seiten, eBook
Sobin / Saeian / Sanvanson Managing Complex Cases in Gastroenterology
1. Auflage 2024
ISBN: 978-3-031-48949-5
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
A Curbside Guide
E-Book, Englisch, 427 Seiten, eBook
ISBN: 978-3-031-48949-5
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Weitere Infos & Material
Part I: General GI.- Chapter 1: Introduction.- Chapter 2: Eosinophilic esophagitis.- Chapter 3: Oropharyngeal dysphagia.- Chapter 4: Achalasia.- Chapter 5: Other motility disorders of the esophagus and achalasia.- Chapter 6: GERD.- Chapter 7: Refractory GERD.- Chapter 8: Surgery for GERD.- Chapter 9: Barrett's esophagus.- Chapter 10: PEG Tubes.- Chapter 11: Autoimmune metaplastic atrophic gastritis.- Chapter 12: Subepithelial lesions and NETs.- Chapter 13: Viewpoints on managing common clinical GI disorders from a practitioner with over 50 Years of “Real-World” experience.- Chapter 14: Small intestinal bacterial overgrowth.- Chapter 15: Unusual causes of abdominal pain and controversies in diagnosis.- Chapter 16: Vascular disorders of the intestine.- Chapter 17: Polypectomy.- Chapter 18: Rectal incontinence.- Chapter 19: Diverticulitis.- Chapter 20: Pancreatic cysts and recurrent pancreatitis.- Chapter 21: Chronic pancreatitis.- Chapter 22: GI oncology.- Chapter 23: Issues in therapeutic endoscopy.- Chapter 24: GI pharmacology.- Part II: IBD Compendium.- Chapter 25: Introduction.- Chapter 26: Crohn’s ileitis.- Chapter 27: Ulcerative colitis refractory to mesalamine.- Chapter 28: Managing Crohn’s in a patient with prior MI.- Chapter 29: Managing post-op Crohn’s.- Chapter 30: Managing pseudopolyps.- Chapter 31: Ulcerative colitis refractory to anti-TNFs.- Chapter 32: Severe ulcerative colitis.- Chapter 33: Resistant/refractory proctitis.- Chapter 34: Vaccinations in newly diagnosed IBD.- Chapter 35: Ustekinumab vs risankizumab in Crohn’s.- Chapter 36: Use of vedolizumab in UC.- Chapter 37: Functional diarrhea in IBD.- Chapter 38: When to postpone infusions.- Chapter 39: Musculoskeletal complaints in a patient on anti-TNFs.- Chapter 40: Use of immune modulators in patients being started on anti-TNFs.-Chapter 41: Pyoderma gangrenosum.- Chapter 42: UC in a patient who failed mesalamine and anti-TNF.- Chapter 43: Patients with IBD who are squeamish about rectal meds and self-injection.- Chapter 44: Colon stricture in UC.- Chapter 45: Nonspecific ileal ulcers.- Chapter 46: Concern about Pneumocystis jirovecii.- Chapter 47: Bloating in Crohn’s.- Chapter 48: Severe diarrhea in a patient on chemotherapy.- Chapter 49: Microscopic colitis.- Chapter 50: Miscellaneous questions.- Part III: Disorders of the Gut-Brain Interaction.- Chapter 51: Introduction.- Chapter 52: IBS-D.- Chapter 53: IBS-C.- Chapter 54: Functional dyspepsia.- Chapter 55: Bloating.- Part IV: Hepatology Compendium.- Chapter 56: Introduction.- Chapter 57: Liver enzyme elevation-negative work-up.- Chapter 58: Increased LFTs with increased iron.- Chapter 59: Increased LFTs with low ceruloplasmin.- Chap^ALT.- Chapter 64: Marked hyperbilirubinemia.- Chapter 65: Suspected NAFLD.- Chapter 66: Treatment of NAFLD.- Chapter 67: Treatment of MASLD.- Chapter 68: Alcohol and liver disease in women.- Chapter 69: Alcoholic hepatitis.- Chapter 70: Fatty Liver on ultrasound with normal liver enzymes.- Chapter 71: Evaluation for liver damage from chronic alcohol use.- Chapter 72: Ascites in a patient without obvious cirrhosis.- Chapter 73: Ascites in a patient with cirrhosis of unclear etiology with increased mononuclear cells.- Chapter 74: Low SAAG ascites.- Chapter 75: Banding esophageal varices.- Chapter 76: Gastric varices.- Chapter 77: Increased ascites in a stable cirrhotic.- Chapter 78: Complications related to managing ascites.- Chapter 79: Portal vein thrombosis as a complication of cirrhosis.- Chapter 80: Portal vein thrombosis and Budd-Chiari in a patient with ulcerative colitis.- Chapter 81: HCC management, solitary lesion in a Child’s A cirrhotic.- Chapter 82: Management of Unresectable HCC in a Cirrhotic.- Chapter 83: HCC in NAFLD without Cirrhosis.- Chapter 84: Managing primary biliary cholangitis.- Chapter 85: Advanced PBC.- Chapter 86: Autoimmune hepatitis.- Chapter 87: Autoimmune hepatitis.- Chapter 88: Primary sclerosing cholangitis.- Chapter 89: PBC-AIH overlap.- Chapter 90: Immune-tolerant chronic HBV.- Chapter 91: Immune-active chronic HBV.- Chapter 92: HBV treatment discontinuation.- Chapter 93: Differentiating acute HBV from an acute exacerbation of chronic HBV.- Chapter 94: Acute HBV and risk of HBV reactivation.- Chapter 95: Complicated HCV.- Chapter 96: Acute liver failure.- Chapter 97: Delayed presentation of Tylenol overdose.- Chapter 98: Candidates for liver transplant?.- Chapter 99: Frustrations with waiting for a liver transplant.- Chapter 100: Complications post liver transplant.